Competing endogenous RNA networks in ovarian cancer: from bench to bedside

Roghaiyeh Derogar1, Fatemeh Nejadi Orang2, Mahdi Abdoli Shadbad3

  • 1Fellowship in Gynecologic Oncology, Department of Gynecology, Faculty of Medical Sciences, Tabriz Medical Sciences, Islamic Azad University, Tabriz, Iran.

EXCLI Journal
|February 19, 2025
PubMed

Insights

This review explores competing endogenous RNA (ceRNA) networks, including microRNAs (miRNAs), circular RNAs (circRNAs), and long non-coding RNAs (lncRNAs), in epithelial ovarian cancer. These networks offer new diagnostic biomarkers and therapeutic targets for improved patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Epithelial ovarian cancer (EOC) is a leading cause of cancer-related deaths, characterized by invasiveness and chemoresistance.
  • MicroRNAs (miRNAs), circular RNAs (circRNAs), and long non-coding RNAs (lncRNAs) play crucial roles in EOC development.
  • Competing endogenous RNA (ceRNA) networks, involving these non-coding RNAs, regulate gene expression in EOC cells.

Purpose of the Study:

  • To provide a comprehensive review of ceRNA networks in epithelial ovarian cancer.
  • To highlight the significance of ceRNAs in oncogenesis, treatment, diagnosis, and prognosis.
  • To discuss future perspectives, including single-cell RNA sequencing and personalized medicine.

Main Methods:

  • Literature review of recent findings on ceRNA networks in ovarian cancer.
  • Analysis of the roles of miRNAs, circRNAs, and lncRNAs in EOC hallmarks.
  • Exploration of ceRNA networks as biomarkers and therapeutic targets.

Main Results:

  • ceRNA networks significantly impact gene expression in ovarian cancer.
  • circRNA- and lncRNA-mediated ceRNA networks offer potential as diagnostic biomarkers.
  • These networks present opportunities for targeted therapies against ovarian cancer.

Conclusions:

  • ceRNA networks are integral to ovarian cancer progression and present therapeutic vulnerabilities.
  • Understanding ceRNA networks can lead to improved diagnostic and prognostic tools.
  • Future research directions include leveraging single-cell RNA sequencing for personalized ovarian cancer medicine.